Sign in to view content

Should We Ever Consider Stopping Treatment for Neovascular AMD?

Rahul N. Khurana, MD, FASRS

Video
Published 2020

Related

Impact of Race on Vision Outcomes in Ranibizumab-Treated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trials
M. Ali Khan, MD, FACS, FASRS
Annual Meeting Talks
2021
Episode 1: Review of the Clarity Study with Dr. Amin Kherani
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
96-Week Visual and Expanded Anatomical Outcomes of Brolucizumab Versus Aflibercept in Patients With nAMD: Results From HAWK and HARRIER
Chirag D. Jhaveri, MD, FASRS
Annual Meeting Talks
2019

Category: Age-Related Macular Degeneration

See more